Effect of population and gender on chemotherapeutic agent-induced cytotoxicity

Molecular Cancer Therapeutics

Volumn 6, Issue 1, 2007, Pages 31-36

  Huang, Rong Stephanie ^a   Kistner, Emily O ^a   Bleibel, Wasim K ^a   Shukla, Sunita J ^a   Dolan, M Eileen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DAUNORUBICIN; ETOPOSIDE;

ADULT; ARTICLE; CELL VIABILITY; CHILD; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SENSITIVITY; FEMALE; GENETIC VARIABILITY; HAPLOTYPE MAP; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC 50; LYMPHOBLASTOID CELL LINE; MALE; PHARMACOGENETICS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE; CELL SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MALE; PHARMACOGENETICS; SEX CHARACTERISTICS;

EID: 33846807430     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-06-0591     Document Type: Article

References (17)

1. Spitz MR, Wu X, Mills G. Integrative epidemiology: from risk assessment to outcome prediction. J Clin Oncol 2005;23:267-75.
2. Millward MJ, Boyer MJ, Lehnert M, et al. Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann Oncol 2003; 14:449-54.
3. Hasan S, Dinh K, Lombardo F, Kark J. Doxorubicin cardiotoxicity in African Americans. J Natl Med Assoc 2004;96:196-9.
4. Jeremic B, Milicic B, Dagovic A, Aleksandrovic J, Milisavljevic S. Stage III non-small-cell lung cancer treated with high-dose hyperfractionated radiation therapy and concurrent low-dose daily chemotherapy with or without weekend chemotherapy. Am J Clin Oncol 2004;27:350-60.
5. Jeremic B, Milicic B, Dagovic A, Aleksandrovic J, Nikolic N. Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy. J Cancer Res Clin Oncol 2003;129:114-22.
6. Gunduz K, Gunalp I, Yalcindag N, et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology 2004;111:1917-24.
7. Shields CL, Mashayekhi A, Carter J, Shelil A, Meadows AT, Shields JA. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol 2004;138: 329-37.
8. Puchner MJA, Herrmann H-D, Berger J, Cristante L. Surgery, tamoxifen, carboplatin, and radiotherapy in the treatment of newly diagnosed glioblastorna patients. J Neurooncol 2000;49:147-55.
9. Dimopoulou I, Efstathiou E, Samakovli A, et al. A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment. Ann Oncol 2004;15: 1250-5.
10. Goldberg SL, Chiang L, Selina N, Hamarman S. Patient perceptions about chemotherapy- induced oral mucositis: implications for primary/ secondary prophylaxis strategies. Support Care Cancer 2004;12:526-30.
11. Shord SS, Thompson DM, Krempl GA, Hanigan MH. Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer. Anticancer Drugs 2006;17:207-15.
12. Mercado G, Adelstein DJ, Saxton JP, Secic M, Larto MA, Lavertu P. Hypothyroidism. Cancer 2001;92:2892-7.
13. Dabholkar M, Vionnet J, Bostick-Bruton F, Yu JJ, Reed E. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. J Clin Invest 1994;94:703-8.
14. Hensing TA, Schell MJ, Lee J-H, Socinski MA. Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer. Lung Cancer 2005;47:253-9.
15. Zhang W, Bleibel WK, Roe CA, Cox NJ, Dolan ME. Gender-specific differences in expression in lymphoblastoid cell lines. Pharmacogenetics and genomics. In press 2007.
16. Huang CC, Moore GE. Chromosomes of 14 hernatopoietic cell lines derived from peripheral blood of persons with and without chromosome anomalies. J Natl Cancer Inst 1969;43:1119-28.
17. Cheung V, Conlin L, Weber T, et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 2003;33: 422-5.